January 09, 2025

CDC Expands Adult Pneumococcal Vaccine Age Range

CDC recommends pneumococcal vaccines for adults 50+, expanding previous age-based guidance.

Conexiant

July 12, 2023

Changing How Immune Checkpoint Inhibitors Are Delivered Could Reduce Costs by 14%, Study Finds

Investigators have found that millions of dollars could be saved annually across the Veterans Health Administration by reconsidering how immune checkpoint inhibitors are delivered, according to a new ...

The ASCO Post

October 29, 2024

New Data Challenges Pediatric Sinusitis Treatment Guidelines

A JAMA review revealed that only 26% of pediatric ABRS patients treated with placebo required subsequent antibiotic therapy, prompting questions about current guidelines recommending first-line antibiotic use in children with sinusitis.

Conexiant

November 13, 2024

Is COPD Set to Affect 600M Globally?

GOLD 2025 highlights new pathways and advanced COPD therapies like ensifentrine and dupilumab to reduce exacerbations and address emerging COPD phenotypes.

Conexiant

June 02, 2024

Telehealth Shown to Be Effective for Palliative Care Delivery in Patients With Advanced Lung Cancer

New research presented at the 2024 ASCO Annual Meeting reinforces the telehealth delivery of palliative care as an effective alternative to in-person visits for patients with advanced lung cancer, pro...

The ASCO Post

December 02, 2024

2024 Vitamin D Guidelines: A Critical Review

"If the pharmaceutical industry had developed a single drug capable of reducing cancer mortality by 25%, autoimmune disorders by 39%, and COVID-19 infection rates by 74%, it would be heralded as a miracle drug."

Conexiant

May 08, 2024

Forget Ringing the Button for the Nurse. Patients Now Stay Connected by Wearing One.

The BioButton is revolutionizing patient monitoring by employing artificial intelligence to analyze vital signs, improving care, and reducing the workload of nurses at Houston Methodist Hospital.

KFF Health News

December 05, 2024

FDA Approves Durvalumab for Limited-Stage Small Cell Lung Cancer

On December 4, 2024, the U.S. Food and Drug Administration approved durvalumab (Imfinzi) for adults with limited-stage small cell lung cancer (SCLC) whose disease has not progressed following concurre...

The ASCO Post

April 29, 2024

CRN Sets New Safety Standards for Melatonin and Gummy Supplements

Discover how the Council for Responsible Nutrition's new voluntary guidelines for melatonin and gummy dietary supplements aim to improve consumer safety and product integrity, focusing on labeling, packaging, and formulation to enhance trust and compliance in the industry.

Conexiant